Ottawa Methods Centre (OMC)


Recent news at the Ottawa Methods Centre

New research shows cystic fibrosis patients in Ontario are at risk for infection with dangerous strain of bacteria


New research published in the Journal of the American Medical Association (JAMA) suggests that 15 per cent of Ontario Cystic Fibrosis (CF) patients are infected with a strain of bacteria that makes them twice as likely to die or require a lung transplant...

Outstanding researchers at uOttawa and OHRI to receive significant funding


The Ontario Ministry of Research and Innovation today announced $3.6 million dollars in funding to support the outstanding research being conducted by professors and students from the University of Ottawa and the Ottawa Hospital Research Institute. Eight research projects, in areas such as health and medicine, nanophotonics, physics and visual arts...

Cochrane Canada receives $9.6M from CIHR


The Canadian Institutes of Health Research recently announced $9.6 million in funding over the next five years to Cochrane Canada to help fulfill its mission of cultivating evidence-based health decision-making by promoting the use and accessibility of Cochrane Reviews. Cochrane Canada is led by Dr. Jeremy Grimshaw at OHRI...

Nine leading medical journals publish clinical trial reporting guidelines developed by Ottawa researcher


New guidance to improve the reporting of trial findings is published simultaneously today by nine leading medical journals. Full and transparent reporting of trials is crucial to ensure that decisions about health care are based on the best available evidence...

Ottawa researchers develop guidelines for better reporting of health research


A paper published in this week's issue of PLoS Medicine provides a substantial new resource for developing guidelines for reporting health research. The paper was written by Dr. David Moher of the Ottawa Hospital Research Institute and the University of Ottawa, along with colleagues from the U.S. and the U.K...

OHRI awarded $7.8M from Canadian Institutes of Health Research


Fifteen OHRI / uOttawa scientists have been awarded grants worth a total of $7.8M from the Canadian Institutes of Health Research (CIHR). This funding will help the researchers develop better therapies, answer important health questions and make our health care system more effective and efficient...

Ottawa Hospital Gala raises impressive amount for groundbreaking research


The 2009 Ottawa Hospital Gala was a tremendous success raising $120,000 for the Ottawa Hospital Research Institute. Drs. Jeremy Grimshaw, Johné Liu and Mitchell Baldwin were honoured for their research in knowledge translation, cell biology and brain cancer, respectively...

Improving care for people with neck injuries: Ottawa hospital-led study paves the way for worldwide adoption of Canadian C-Spine Rule


A 12-hospital clinical trial has shown that active promotion of the Canadian C-Spine Rule in emergency departments can significantly reduce the use of unnecessary neck x-rays without compromising the detection of serious neck injuries...

Ottawa rehabilitation researchers find simulated space travel increases bone marrow fat


As a specialist at The Ottawa Hospital Rehabilitation Centre, Dr. Guy Trudel has always been interested in improving how patients recover from long term injuries and immobility, so when an opportunity arose to study a similar problem in the unique context of space...

OHRI / uOttawa research shows heart rate monitors could help detect sepsis earlier


A new research study led by Dr. Andrew Seely and Dr. Saif Ahmad shows that a simple heart rate monitor may be able to detect the first signs of sepsis, a potentially lethal blood infection, almost a day and a half before traditional methods. The researchers developed a sophisticated mathematical algorithm to analyze variation in heart rate and detect patterns...

Five top medical journals publish research guidelines developed in Ottawa


An international group led by Dr. David Moher of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa has today released guidelines to improve how highly influential reviews of medical and health research are reported...

Study points to need for more training in clinical trial design in China


A survey of more than 3,000 randomized clinical trials published in Chinese journals suggests that less than 10 per cent are actually randomized according to accepted guidelines. The survey, published in BioMed Central’s open access journal, Trials, was led by Dr. David Moher of Ottawa, Canada and Dr. Taixiang Wu of Sichuan, China.

OHRI awarded $12M for national network to translate clinical research results into better health


The Ottawa Hospital Research Institute (OHRI), an affiliated institute of the University of Ottawa, has been awarded $12.2M to lead a groundbreaking new national research network called Knowledge Translation Canada (KT Canada)...

Free access to Cochrane Library health information for all Canadians


The Canadian Cochrane Network and Centre, led by OHRI scientist Dr. Jeremy Grimshaw, announced today that everyone in Canada with access to the Internet will be able to view the full content of The Cochrane Library, an online resource that provides evaluations on health treatments...

Genes and disease: OHRI scientists contribute to guidelines for reporting genetic associations


Several high-profile medical journals are publishing the results of a recent initiative designed to enhance the transparency of reporting in genetic-association studies — performed to determine whether a genetic variant is associated with a disease or trait.

Aprotinin associated with increased risk of death: Canadian trial published in NEJM compares three drugs routinely used to prevent blood loss during heart surgery


Aprotinin is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart surgery. The trial, published in the New England Journal of Medicine, shows that approximately six per cent of patients who received aprotinin died within 30 days of surgery compared to four per cent of patients who received tranexamic acid or aminocaproic acid.